Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Male, Christoph
NCT02932618 / 2016-001477-33: A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)	Recruiting	3	34	Europe, US, RoW	von Willebrand factor (Recombinant), VONVENDI, rVWF, BAX111, BAX 111, Antihemophilic Factor (Recombinant), ADVATE, Recombinant Factor VIII, rFVIII	Baxalta now part of Shire, Takeda Development Center Americas, Inc.	Von Willebrand Disease	01/25	01/25
PedNet, NCT02979119: The European Paediatric Network for Haemophilia Management ( Registry)	Recruiting	N/A	4000	Europe, Canada, RoW		PedNet Haemophilia Research Foundation, Lund University Hospital	Factor VIII Deficiency, Factor IX Deficiency	12/29	12/29